Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice

Am J Physiol Renal Physiol. 2015 May 1;308(9):F981-92. doi: 10.1152/ajprenal.00597.2014. Epub 2015 Feb 18.

Abstract

Recently, we demonstrated in female mice that protection against ANG II-induced hypertension and associated cardiovascular changes depend on cytochrome P-450 (CYP)1B1. The present study was conducted to determine if Cyp1b1 gene disruption ameliorates renal dysfunction and organ damage associated with ANG II-induced hypertension in female mice. ANG II (700 ng·kg(-1)·min(-1)) infused by miniosmotic pumps for 2 wk in female Cyp1b1(+/+) mice did not alter water consumption, urine output, Na(+) excretion, osmolality, or protein excretion. However, in Cyp1b1(-/-) mice, ANG II infusion significantly increased (P < 0.05) water intake (5.50 ± 0.42 ml/24 h with vehicle vs. 8.80 ± 0.60 ml/24 h with ANG II), urine output (1.44 ± 0.37 ml/24 h with vehicle vs. 4.30 ± 0.37 ml/24 h with ANG II), and urinary Na(+) excretion (0.031 ± 0.016 mmol/24 h with vehicle vs. 0.099 ± 0.010 mmol/24 h with ANG II), decreased osmolality (2,630 ± 79 mosM/kg with vehicle vs. 1,280 ± 205 mosM/kg with ANG II), and caused proteinuria (2.60 ± 0.30 mg/24 h with vehicle vs. 6.96 ± 0.55 mg/24 h with ANG II). Infusion of ANG II caused renal fibrosis, as indicated by an accumulation of renal interstitial α-smooth muscle actin, collagen, and transforming growth factor-β in Cyp1b1(-/-) but not Cyp1b1(+/+) mice. ANG II also increased renal production of ROS and urinary excretion of thiobarburic acid-reactive substances and reduced the activity of antioxidants and urinary excretion of nitrite/nitrate and the 17β-estradiol metabolite 2-methoxyestradiol in Cyp1b1(-/-) but not Cyp1b1(+/+) mice. These data suggest that Cyp1b1 plays a critical role in female mice in protecting against renal dysfunction and end-organ damage associated with ANG II-induced hypertension, in preventing oxidative stress, and in increasing activity of antioxidant systems, most likely via generation of 2-methoxyestradiol from 17β-estradiol.

Keywords: angiotensin II; cytochrome P-450 1B1-deficient female mice; increased oxidative stress; kidney dysfunction; reduced antioxidant activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II*
  • Animals
  • Catalase / metabolism
  • Cytochrome P-450 CYP1B1 / deficiency
  • Cytochrome P-450 CYP1B1 / genetics
  • Cytochrome P-450 CYP1B1 / metabolism*
  • Disease Models, Animal
  • Drinking
  • Estradiol / analogs & derivatives
  • Estradiol / urine
  • Female
  • Fibrosis
  • Genotype
  • Hypertension / complications*
  • Hypertension / enzymology
  • Hypertension / genetics
  • Hypertension / physiopathology
  • Kidney / enzymology*
  • Kidney / pathology
  • Kidney / physiopathology
  • Kidney Diseases / enzymology
  • Kidney Diseases / etiology*
  • Kidney Diseases / genetics
  • Kidney Diseases / pathology
  • Kidney Diseases / physiopathology
  • Kidney Diseases / prevention & control
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NADPH Oxidases / metabolism
  • Natriuresis
  • Oxidative Stress
  • Phenotype
  • Renin-Angiotensin System
  • Sex Factors
  • Superoxide Dismutase / metabolism
  • Superoxides / metabolism
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • Urination

Substances

  • Superoxides
  • Angiotensin II
  • 2-methylestradiol
  • 3-nitrotyrosine
  • Tyrosine
  • Estradiol
  • Catalase
  • Cyp1b1 protein, mouse
  • Cytochrome P-450 CYP1B1
  • Superoxide Dismutase
  • NADPH Oxidases